Literature DB >> 7178822

Epidemiology and dynamics of gastritis in a representative sample of an Estonin urban population.

K Villako, M Kekki, A Tamm, R Tammur, E Savisaar, V Viirsalu, P Sipponen.   

Abstract

The epidemiology and dynamics of gastritis were studied in a representative sample of an urban population of Estonia. The sample consisted of 227 subjects 15-69 years old who were examined by direct-vision endoscopic biopsy, and the data were subjected to dynamic evaluation by stochastic principles. The prevalence of antral gastritis (64%) was similar to but that of body gastritis (62%) higher than that in other population samples studied by us. Correspondingly, the prevalence of atrophic antral and body gastritis was high: 38% and 37%, respectively. The prevalence of atrophic gastritis in the antrum and body increased significantly with age. On the other hand, no sex dependence of gastritis could be demonstrated. The prevalence of gastritis mainly affecting the body (32%) was significantly higher in the present than in the other Estonian sample (19%) studied by us. Complete loss of normal body glands was found in 14 subjects, and in 8 of these the antrum was normal or only slightly altered (type A gastritis). The prevalence of gastritis mainly affecting the body increased significantly with age, whereas that of gastritis mainly affecting the antrum decreased. Dynamic evaluation disclosed two basic dynamic patterns similar to those found in other population samples: the age-specific prevalences of gastritis increased with age according to the Poisson process, and gastritis started in the antrum at a younger age, but its progression was more rapid in the body mucosa. Dynamically, the chief finding of the sample was markedly more rapid progression of the body gastritis than in other samples, which explains the high prevalence of gastritis mainly affecting the body mucosa (type A gastritis) in the present series.

Entities:  

Mesh:

Year:  1982        PMID: 7178822     DOI: 10.3109/00365528209181065

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Gastric cancer: an epidemiological review.

Authors:  S A Matthews
Journal:  Environ Geochem Health       Date:  1990-09       Impact factor: 4.609

2.  Relation of parietal cell and thyroid antibodies to the state of gastric mucosa and basal serum gastrin levels during a 6-year follow up.

Authors:  R Uibo; K Krohn; K Villako; R Tammur; A Tamm
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

3.  Demonstration of gastrin cell autoantibodies in antral gastritis with avidin-biotin complex antibody technique.

Authors:  R M Uibo; K J Krohn
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

4.  Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.

Authors:  R J Schlemper; S D van der Werf; J P Vandenbroucke; I Biemond; C B Lamers
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

5.  Helicobacter pylori and early gastric cancer.

Authors:  M E Craanen; P Blok; W Dekker; G N Tytgat
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

6.  Types of atrophic gastritis in patients with primary Sjögren's syndrome.

Authors:  G Pokorny; G Karácsony; J Lonovics; J Hudák; J Németh; V Varró
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

Review 7.  Chronic gastritis.

Authors:  Pentti Sipponen; Heidi-Ingrid Maaroos
Journal:  Scand J Gastroenterol       Date:  2015-04-22       Impact factor: 2.423

8.  Gastroduodenal Changes Two Years After Eradication of Helicobacter pylori in a Population-Based Cohort.

Authors:  Stefan Redeen; Fredrik Petersson; Stergios Kechagias; Jens Rehfeld; Kurt Borch
Journal:  Gastroenterology Res       Date:  2015-04-03

9.  Atrophic gastritis and vitamin C status in two towns with different stomach cancer death-rates.

Authors:  M L Burr; I M Samloff; C J Bates; R M Holliday
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.